AstraZeneca vaccine 100% effective against severe disease, new trial suggests

AstraZeneca's Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday. Pročitaj više